Evidence map›Paper›PMID 34940708›Full record

ArticleMarine drugs2021

From Crystal Structures of RgIA4 in Complex with

Si Pan, Yingxu Fan, Xiaopeng Zhu, Yi Xue, Sulan Luo, Xinquan Wang

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. In Silico Conotoxin Studies: Progress and Prospects.Molecules (Basel, Switzerland) · 2024
    Review
  3. Mitogenome Characterization of FourInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Si PanKey Laboratory of Translational Tumor Medicine in Fujian Province, Putian University, Putian 351100, China.ORCID 0000-0003-4866-2639
Yingxu FanTsinghua-Peking Joint Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing 100084, China.
Xiaopeng ZhuMedical School, Guangxi University, Nanning 530004, China.ORCID 0000-0001-8830-4954
Yi XueTsinghua-Peking Joint Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing 100084, China.
Sulan LuoMedical School, Guangxi University, Nanning 530004, China.ORCID 0000-0002-9358-5970
Xinquan WangBeijing Advanced Innovation Center for Structural Biology, Collaborative Innovation Center for Biotherapy, The Ministry of Education Key Laboratory of Protein Science, School of Life Sciences, Tsinghua University, Beijing 100084, China.
Center for Life Sciences · CNGuangxi University · CNPutian University · CNTsinghua University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

α9-containing nicotinic acetylcholine receptors (nAChRs) have been shown to play critical roles in neuropathic pain. The α-conotoxin (α-CTx) RgIA and its analog RgIA4 were identified as the most selective inhibitor of α9α10 nAChR. However, the mechanism of their selectivity toward α9α10 nAChR remains elusive. Here, we reported the co-crystal structure of RgIA and RgIA4 in complex with

Indexed as

AplysiaAcetylcholineAnimalsAquatic OrganismsConotoxinsHumansMolecular Dynamics SimulationNicotinic AntagonistsReceptors, NicotinicAcetylcholineConotoxinsNicotinic AntagonistsReceptors, Nicotinicacetylcholine binding proteincrystal structuremolecular dynamics simulationnicotinic acetylcholine receptorsRgIARgIA4α-conotoxin

Identifiers

PMID34940708
PMCPMC8709174
OpenAlexW4200421619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.